Whether hysteroscopic removal of retained products of conception is better than blind dilatation and curettage

Comparative study of hysteroscopic management versus blind dilatation and curettage in women with retained products of conception following first trimester abortion - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073619

Enrollment

Registered

2024-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Hysteroscopic removal of retained products of conception: Hysteroscopic resection will be carried out with a standard 26 F continuous flow bipolar resectoscope fitted with a 4mm cutting

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with retained product of conception with size more than 12mm following incomplete spontaneous or induced abortion in first trimester within 12 weeks of amenorrhea

Exclusion criteria

Exclusion criteria: 1 Infection as demonstrated by foul smelling discharge and tenderness on pelvic examination 2 Size of RPOCs more than 5cm 3 Heavy vaginal bleeding with hemodynamic instability

Design outcomes

Primary

Measure	Time frame
To compare the proportion of women with no visible RPOCs on ultrasound done 48 hours post procedure in the both groups.Timepoint: 48 hours	—

Secondary

Measure	Time frame
1. To compare fall in haemoglobin and increase in leukocyte count in both groups assessed 48 hours post procedure. 2. To compare proportion of women with complications such as perforation, heavy bleeding and fever in both groups assessed at 48 hours and 6 weeks post procedure. 3. To compare number of days requiring analgesia in both groups assessed 6 weeks post procedure. 4. To compare the change in menstrual pattern as assessed by PBAC score (between pre procedure and 3 months post procedure) in both groups. Timepoint: 3 months	—

Measure

Time frame

1. To compare fall in haemoglobin and increase in leukocyte count in both groups assessed 48 hours post procedure. 2. To compare proportion of women with complications such as perforation, heavy bleeding and fever in both groups assessed at 48 hours and 6 weeks post procedure. 3. To compare number of days requiring analgesia in both groups assessed 6 weeks post procedure. 4. To compare the change in menstrual pattern as assessed by PBAC score (between pre procedure and 3 months post procedure) in both groups. Timepoint: 3 months

—

Countries

India

Contacts

Public ContactDr Swati Agrawal

Lady Hardinge Medical College

drswatilhmc@gmail.com8882772683

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026